H. Lundbeck A/S (HLUN-A.CO) — Stock Score Summary

H. Lundbeck A/S (HLUN-A.CO) has a MoatMap StockRank of 99/100 based on Quality (70/100), Value (77/100), and Momentum (57/100) factor scores. The current signal is STRONG BUY.

Key Financial Metrics

Price$5.73
Market Cap$5.5B
P/E (TTM)9.73
Price/Book1.46
Return on Equity14.9%
Return on Invested Capital11.6%
Debt/Equity42.64
Gross Margin82.4%
Operating Margin30.2%
Revenue Growth14.3%
Dividend Yield3.2%
Free Cash Flow$120M

H. Lundbeck A/S operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (Denmark).

Frequently Asked Questions

What is H. Lundbeck A/S’s (HLUN-A.CO) StockRank?
MoatMap’s StockRank for H. Lundbeck A/S (HLUN-A.CO) is 99/100, with a Strong Buy signal. It is a composite of Quality (70), Value (77), and Momentum (57) factor ranks across MoatMap’s 19,000+ stock universe.
Does H. Lundbeck A/S have an economic moat?
H. Lundbeck A/S (HLUN-A.CO) has a Quality factor score of 70/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is H. Lundbeck A/S a buy, hold, or sell?
MoatMap’s current signal for H. Lundbeck A/S (HLUN-A.CO) is Strong Buy, based on a StockRank of 99/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is H. Lundbeck A/S in?
H. Lundbeck A/S (HLUN-A.CO) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (Denmark).